Form D · Pharmaceuticals

ACON Injectable Investors I, L.P.

Washington, DC · CIK 0001865102

Offering snapshot reported Jun 1, 2021 · SEC filing

Reported sold
$59M
Offering amount: $74M
Investors reported
Not reported
Form D · investor count
Minimum accepted
Not reported
Reported outside-investor minimum
First sale
Not reported
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jun 1, 2021Initial$59,040,000No comparisonNot reportedSEC filing

Offering details

Securities
Not reported
Exemptions
Not reported
Duration over one year
Not reported
Business combination
Not reported
Sales commissions
Not reported
Finders' fees
Not reported
Form D file number
021-401230

Source: Form D, filed Jun 1, 2021. Minimum accepted may differ from a standard advertised minimum.

Fund connections

The linked fund shows its most recently reported ADV details.

Matched by reported Form D file number

ACON INJECTABLE INVESTORS I, L.P.

Investment adviser: ACON LATAM MANAGEMENT, L.L.C.

Gross asset value
$13.4M
Beneficial owners
8
ADV minimum commitment
$500K

Reported in Form ADV on Sep 1, 2026. Fund assets and beneficial owners measure different things from Form D sales and investors.

Service providers

Fund administrator SEI GLOBAL SERVICES, INC. OAKS, Pennsylvania, United States Investor statements: Yes (provided to all investors) Related to adviser: No
Auditor PRICEWATERHOUSECOOPERS MCLEAN, Virginia, United States
Custodian WELLS FARGO BANK, N.A. MCLEAN, Virginia, United States Related to adviser: No
Provider details
Annual audit
Yes
Prime brokers
No
Custodians
Yes
Administrator other than the adviser
Yes
External marketing
No

PRICEWATERHOUSECOOPERS
PCAOB 238

WELLS FARGO BANK, N.A.
LEI KB1H1DSPRFMYMCUFXT09

Filing source

Form ADV 2129084 · Sep 1, 2026 · Schedule D 7.B.(1), fund 805-5112754342

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
N/A Alaof V Gen Par, L.L.C. Promoter
Teresa Y. Bernstein Executive
Jose Knoell Executive
Masumi Waida Executive

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
C/O Alaof V Genpar, L.L.C. 1133 Connecticut Avenue N.W., Suite 700
Washington, DC, 20036